Chemists from ETH Zurich have found a way to produce poorly soluble proteins by caging a uniquely reactive boron compound. This method opens up new possibilities for the synthesis of tailored protein ...
Boron agents termed GluBs, developed by Science Tokyo researchers, have overcome a key limitation in cancer therapy by entering tumor cells through a pathway that standard drugs cannot use. The GluBs ...
News Medical on MSN
Boron neutron capture therapy shows promise for deadly brain tumors
Malignant gliomas are among the deadliest brain cancers, with limited treatment options and poor survival. A new comprehensive review analyzes decades of global clinical data on boron neutron capture ...
Replacing a hydrogen atom in the drug with a boron-fluorine compound, boracycle, opens up great opportunities to modify the drug's properties. In this illustration, the boron-fluorine compound has ...
A major step toward simpler drug development has been taken at the University of Gothenburg. In a new study, researchers have developed stable boron-fluorine compounds that make it possible to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results